Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Boehringer Ingelheim
Dow
Merck
Baxter

Last Updated: December 16, 2019

DrugPatentWatch Database Preview

Litigation Details for Pronova BioPharma Norge AS v. Par Pharmaceutical Inc. (D. Del. 2010)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Pronova BioPharma Norge AS v. Par Pharmaceutical Inc. (D. Del. 2010)

Docket   Start Trial Date Filed 2010-09-20
Court District Court, D. Delaware Date Terminated 2011-07-27
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To Mary Pat Thynge
Parties PAR PHARMACEUTICAL COMPANIES INC.; PAR PHARMACEUTICAL INC.; PRONOVA BIOPHARMA NORGE AS
Patents 5,502,077; 5,656,667; 7,732,488
Attorneys Caroline Hong; Steven J. Balick; Steven J. Fineman; Tiffany Geyer Lydon
Link to Docket External link to docket
Small Molecule Drugs cited in Pronova BioPharma Norge AS v. Par Pharmaceutical Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Pronova BioPharma Norge AS v. Par Pharmaceutical Inc. (D. Del. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-09-20 1 Complaint infringement of U.S. Patent No. 7,732,488 (“the ’488 patent”), arising under the United States patent laws, Title…COUNT FOR PATENT INFRINGEMENT 9. The U.S. Patent and Trademark Office (“PTO”) issued the ’488 patent on June…Pollutants.” A copy of the ’488 patent is attached as Exhibit A. 10. The ’488 patent is assigned to Pronova. …of the ’488 patent as recorded by the PTO at Reel 016754, Frame 0279. ll. The ’488 patent expires on …_/\/\_/\~/V\_/\./\/ Defendants. COMPLAINT FOR PATENT INFRINGEMENT Plaintiff Pronova BioPharma Norge External link to document
2010-09-20 3 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,732,488 B2; (dmp, ) (Entered…2010 27 July 2011 1:10-cv-00801 830 Patent None District Court, D. Delaware External link to document
2011-07-27 61 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,732,488 B2. (Attachments: #…2010 27 July 2011 1:10-cv-00801 830 Patent None District Court, D. Delaware External link to document
2010-10-04 8 Redacted Document Page 9 of 20 Page|D #: 44 9. U.S. Patent No. 5,502,077 (“the ’077 patent”), entitled “Fatty acid composition…infringement of U.S, Patent No. 7,732,488 (“the ’488 patent”), arising under the United States patent laws, Titie… FOR PATENT INFRINGEMENT 9. The U.S. Patent and Trademark Office (“PTO”) issued the ’488 patent on June…states a claim for patent infringement Par further denies any infringement of the ’488 patent. .}URISI)ICTION…. 10. The ’488 patent is assigned to Pronova. Pronova is the owner of the ’488 patent as recorded by External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Merck
Johnson and Johnson
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.